Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
REGENERON Pharmaceuticals Inc and Sanofi may get a head start on their biggest competitor in bringing a new class of cholesterol drugs to the US market.
The US Food and Drug Administration (FDA) has until July 24 to make a decision on the companies' application to market...